Abstract:Cellular senescence describes an irreversible growth arrest characterized by distinct morphology, gene expression pattern, and secretory phenotype. The final or intermediate stages of senescence can be reached by different genetic mechanisms and in answer to different external and internal stresses. It has been maintained in the literature but never proven by clearcut experiments that the induction of senescence serves the evolutionary purpose of protecting the individual from development and growth of cancers. This hypothesis was recently scrutinized by new experiments and found to be partly true, but part of the gene activities now known to happen in senescence are also needed for cancer growth, leading to the view that senescence is a double-edged sword in cancer development. In current cancer therapy, cellular senescence is, on the one hand, intended to occur in tumor cells, as thereby the therapeutic outcome is improved, but might, on the other hand, also be induced unintentionally in non-tumor cells, causing inflammation, secondary tumors, and cancer relapse. Importantly, organismic aging leads to accumulation of senescent cells in tissues and organs of aged individuals. Senescent cells can occur transiently, e.g., during embryogenesis or during wound healing, with beneficial effects on tissue homeostasis and regeneration or accumulate chronically in tissues, which detrimentally affects the microenvironment by de- or transdifferentiation of senescent cells and their neighboring stromal cells, loss of tissue specific functionality, and induction of the senescence-associated secretory phenotype, an increased secretory profile consisting of pro-inflammatory and tissue remodeling factors. These factors shape their surroundings toward a pro-carcinogenic microenvironment, which fuels the development of aging-associated cancers together with the accumulation of mutations over time. We are presenting an overview of well-documented stress situations and signals, which induce senescence. Among them, oncogene-induced senescence and stress-induced premature senescence are prominent. New findings about the role of senescence in tumor biology are critically reviewed with respect to new suggestions for cancer therapy leveraging genetic and pharmacological methods to prevent senescence or to selectively kill senescent cells in tumors.

The Dual Role of Oxidative-Stress-Induced Autophagy in Cellular Senescence: Comprehension and Therapeutic Approaches

Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence

A Comprehensive Overview of the Complex Role of Oxidative Stress in Aging, The Contributing Environmental Stressors and Emerging Antioxidant Therapeutic Interventions

The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence

Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies

The evolution of selective autophagy as a mechanism of oxidative stress response: The evolutionarily acquired ability of selective autophagy receptors to respond to oxidative stress is beneficial for human longevity

Oxidative stress and autophagy: the clash between damage and metabolic needs

Autophagy, Oxidative Stress and Cancer Development

The Emerging Role of Oxidative Stress in Regulating Autophagy: Applications of Cancer Therapy.

The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy

Oxidative Stress-Induced Cellular Senescence in Aging Retina and Age-Related Macular Degeneration

Interactions between Oxidative Stress and Senescence in Cancer: Mechanisms, Therapeutic Implications, and Future Perspectives

Oxidative Stress-Induced Cellular Senescence: Is Labile Iron the Connecting Link?

Mitochondrial-Endoplasmic Reticulum Communication-Mediated Oxidative Stress and Autophagy

Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy

Mitochondria-Ros Crosstalk in the Control of Cell Death and Aging

Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases

The Interplay of Autophagy and Oxidative Stress in the Pathogenesis and Therapy of Retinal Degenerative Diseases

The Role of Signaling Pathways of Inflammation and Oxidative Stress in Development of Senescence and Aging Phenotypes in Cardiovascular Disease

ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases

Aging Hallmarks and the Role of Oxidative Stress